Your browser doesn't support javascript.
loading
Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal.
Willmann, Michael; Yuzbasiyan-Gurkan, Vilma; Marconato, Laura; Dacasto, Mauro; Hadzijusufovic, Emir; Hermine, Olivier; Sadovnik, Irina; Gamperl, Susanne; Schneeweiss-Gleixner, Mathias; Gleixner, Karoline V; Böhm, Thomas; Peter, Barbara; Eisenwort, Gregor; Moriggl, Richard; Li, Zhixiong; Jawhar, Mohamad; Sotlar, Karl; Jensen-Jarolim, Erika; Sexl, Veronika; Horny, Hans-Peter; Galli, Stephen J; Arock, Michel; Vail, David M; Kiupel, Matti; Valent, Peter.
Afiliação
  • Willmann M; Department/Hospital for Companion Animals and Horses, Clinic for Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Yuzbasiyan-Gurkan V; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Marconato L; Comparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI, United States.
  • Dacasto M; Department of Veterinary Medical Science, University of Bologna, Ozzano dell'Emilia, Italy.
  • Hadzijusufovic E; Department of Comparative Biomedicine and Food Science, University of Padua, Padua, Italy.
  • Hermine O; Department/Hospital for Companion Animals and Horses, Clinic for Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Sadovnik I; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Gamperl S; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Schneeweiss-Gleixner M; Department of Hematology, Imagine Institute Université de Paris, INSERM U1163, CEREMAST, Necker Hospital, Paris, France.
  • Gleixner KV; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Böhm T; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Peter B; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Eisenwort G; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Moriggl R; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Li Z; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Jawhar M; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Sotlar K; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Jensen-Jarolim E; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Sexl V; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Horny HP; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Galli SJ; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Arock M; Institute of Animal Breeding and Genetics, University of Veterinary Medicine, Vienna, Austria.
  • Vail DM; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hanover Medical School, Hanover, Germany.
  • Kiupel M; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Valent P; Institute of Pathology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
Front Vet Sci ; 8: 755258, 2021.
Article em En | MEDLINE | ID: mdl-34957277
ABSTRACT
Mast cell neoplasms are one of the most frequently diagnosed malignancies in dogs. The clinical picture, course, and prognosis vary substantially among patients, depending on the anatomic site, grade and stage of the disease. The most frequently involved organ is the skin, followed by hematopoietic organs (lymph nodes, spleen, liver, and bone marrow) and mucosal sites of the oral cavity and the gastrointestinal tract. In cutaneous mast cell tumors, several grading and staging systems have been introduced. However, no comprehensive classification and no widely accepted diagnostic criteria have been proposed to date. To address these open issues and points we organized a Working Conference on canine mast cell neoplasms in Vienna in 2019. The outcomes of this meeting are summarized in this article. The proposed classification includes cutaneous mast cell tumors and their sub-variants defined by grading- and staging results, mucosal mast cell tumors, extracutaneous/extramucosal mast cell tumors without skin involvement, and mast cell leukemia (MCL). For each of these entities, diagnostic criteria are proposed. Moreover, we have refined grading and staging criteria for mast cell neoplasms in dogs based on consensus discussion. The criteria and classification proposed in this article should greatly facilitate diagnostic evaluation and prognostication in dogs with mast cell neoplasms and should thereby support management of these patients in daily practice and the conduct of clinical trials.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Vet Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Vet Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria